{"id":"matching-placebo-to-jnj-77242113","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Matching placebos are used in randomized controlled trials to maintain blinding and reduce bias. This placebo is formulated to be indistinguishable from the active JNJ-77242113 drug product in appearance, taste, and administration route, allowing patients and investigators to remain unaware of treatment assignment during the Phase 3 trial.","oneSentence":"This is a placebo control formulation matching the inactive vehicle and appearance of JNJ-77242113 for blinded clinical trial comparison.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:20:17.145Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06095115","phase":"PHASE3","title":"A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2023-10-12","conditions":"Plaque Psoriasis","enrollment":684},{"nctId":"NCT06878404","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-02-21","conditions":"Arthritis, Psoriatic","enrollment":552},{"nctId":"NCT06807424","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-01-09","conditions":"Arthritis, Psoriatic","enrollment":750},{"nctId":"NCT06934226","phase":"PHASE3","title":"A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-04-15","conditions":"Plaque Psoriasis","enrollment":752},{"nctId":"NCT07196722","phase":"PHASE2, PHASE3","title":"A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2025-10-03","conditions":"Crohn Disease","enrollment":1092},{"nctId":"NCT06143878","phase":"PHASE3","title":"A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-02-01","conditions":"Plaque Psoriasis","enrollment":774},{"nctId":"NCT06220604","phase":"PHASE3","title":"A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-03-09","conditions":"Plaque Psoriasis","enrollment":731},{"nctId":"NCT05357755","phase":"PHASE2","title":"A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2022-06-13","conditions":"Plaque Psoriasis","enrollment":90},{"nctId":"NCT05062200","phase":"PHASE1","title":"A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants","status":"COMPLETED","sponsor":"Janssen Pharmaceutical K.K.","startDate":"2021-10-25","conditions":"Healthy","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Matching Placebo to JNJ-77242113","genericName":"Matching Placebo to JNJ-77242113","companyName":"Janssen Research & Development, LLC","companyId":"johnson-johnson","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}